Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany.

Hoa Thi NguyenClaudia M DenkingerStephan BrennerLisa KoeppelLucia BrugnaraRobin BurkMichael KnopTill BärnighausenAndreas DeckertManuela De Allegri

Published in: The European journal of health economics : HEPAC : health economics in prevention and care (2023)

A2 (direct testing at household level) proved to be the most cost-effective of the four evaluated strategies and should be considered as an option to strengthen the routine surveillance system in Germany and similar settings.

Keyphrases

sars cov
clinical trial
public health
open label
clinical practice
respiratory syndrome coronavirus
study protocol
double blind
randomized controlled trial